How big is the Middle East & Africa Feed Anticoccidials Market?

The Middle East & Africa Feed Anticoccidials Market is valued at US$ 70.20 Million in 2023, it is projected to reach US$ 91.26 Million by 2031.

What is the CAGR for Middle East & Africa Feed Anticoccidials Market by (2023 - 2031)?

As per our report Middle East & Africa Feed Anticoccidials Market, the market size is valued at US$ 70.20 Million in 2023, projecting it to reach US$ 91.26 Million by 2031. This translates to a CAGR of approximately 3.3% during the forecast period.

What segments are covered in this report?

The Middle East & Africa Feed Anticoccidials Market report typically cover these key segments- 类型（离子载体、化学抗球虫药和化学离子载体）形态（干态和液态）牲畜（家禽、反刍动物、猪等）

What is the historic period, base year, and forecast period taken for Middle East & Africa Feed Anticoccidials Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Feed Anticoccidials Market report: 2025-2031 2023 2021-2023

Who are the major players in Middle East & Africa Feed Anticoccidials Market?

The Middle East & Africa Feed Anticoccidials Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include: Phibro Animal Health Corp ; Zoetis Inc ; Kemin Industries Inc ; Elanco Animal Health Inc ; Huvepharma EOOD ; Impextraco NV ; Virbac SA.

Who should buy this report?

The Middle East & Africa Feed Anticoccidials Market report is valuable for diverse stakeholders, including: Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns. Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies. Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry. Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies. Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market. Essentially, anyone involved in or considering involvement in the Middle East & Africa Feed Anticoccidials Market value chain can benefit from the information contained in a comprehensive market report.

中东和非洲饲料抗球虫药市场（主要地区、市场参与者、规模和份额）- 预测至 2031 年

2023 年，中东和非洲饲料抗球虫药市场价值为 7020 万美元，预计到 2031 年将达到 9126 万美元；预计 2023 年至 2031 年的复合年增长率为 3.3%。

采用生物航天飞机计划管理球虫病，增强中东和非洲饲料抗球虫药市场

生物航天飞机计划涉及战略性地使用先进技术和实践来预防球虫病并提高鸟类健康和生产性能。生物航天飞机计划中的两个主要成分——疫苗和抗球虫药——结合在一起以改善家禽健康，对该计划的持续有效性至关重要。鸟类在孵化场接种球虫疫苗；然后，在饲料中施用抗球虫药。疫苗均由活艾美耳球虫组成，通过控制球虫暴露和球虫循环来刺激免疫。艾美耳球虫病最常与坏死性肠炎 (NE) 有关，其发病部位位于胃肠道深处。因此，在生物穿梭计划中，疫苗接种后使用饲喂抗球虫药，以降低艾美耳球虫的峰值循环。

生产者可以通过生物穿梭计划将疫苗接种与抗球虫药相结合，提供全面的寄生虫风险防护，从而改善鸡群的整体健康状况。该方案结合饲喂抗球虫药，可在整个生产周期内对抗球虫病，并降低疾病爆发的风险。生物穿梭计划可以提高饲料转化率和增重，同时有助于控制肠道损伤。因此，在预测期内，生物穿梭计划的普及预计将成为饲料抗球虫药市场的一个重要趋势。

中东和非洲饲料抗球虫药市场概览

土耳其、科威特、卡塔尔、巴林、阿曼、埃及和肯尼亚是中东和非洲其他地区饲料抗球虫药市场的主要国家。每个国家都有独特的农业景观和不同程度的家禽养殖活动。饲料抗球虫药的需求源于确保家禽和畜牧业健康和生产性能的需求。抗球虫药在控制影响动物健康的球虫病方面发挥着至关重要的作用。此外，市场增长还受到多种因素的推动，例如政府旨在改善牲畜健康和生产力的举措，以及消费者对安全优质动物产品日益增长的需求。

中东和非洲饲料抗球虫药市场收入及预测至2031年（百万美元）

中东和非洲饲料抗球虫药市场细分

中东和非洲饲料抗球虫药市场根据类型、剂型、牲畜和国家进行细分。根据类型，中东和非洲饲料抗球虫药市场分为离子载体、化学抗球虫药和化学离子载体。2023年，离子载体细分市场占有最大市场份额。

就剂型而言，中东和非洲饲料抗球虫药市场分为干粉和液体。2023年，干粉细分市场占有较大的市场份额。

根据牲畜，中东和非洲饲料抗球虫药市场分为家禽、反刍动物、猪和其他。 2023年，家禽类饲料占据了最大的市场份额。

按国家/地区划分，中东和非洲饲料抗球虫药市场分为阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区。2023年，中东和非洲其他地区占据了中东和非洲饲料抗球虫药市场的主导份额。

Phibro Animal Health Corp、Zoetis Inc、Kemin Industries Inc、Elanco Animal Health Inc、Huvepharma EOOD、Impextraco NV 和 Virbac SA 是中东和非洲饲料抗球虫药市场的一些领先企业。

Middle East & Africa Feed Anticoccidials Strategic Insights

Strategic insights for Middle East & Africa Feed Anticoccidials involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-feed-anticoccidials-market-strategic-framework.webp

Get more information on this report

Middle East & Africa Feed Anticoccidials Report Scope

Report Attribute	Details
Market size in 2023	US$ 70.20 Million
Market Size by 2031	US$ 91.26 Million
Global CAGR (2023 - 2031)	3.3%
Historical Data	2025-2031
Forecast period	2021-2023
Segments Covered	By 类型（离子载体、化学抗球虫药和化学离子载体） By 形态（干态和液态） By 牲畜（家禽、反刍动物、猪等）
Regions and Countries Covered	中东和非洲（沙特阿拉伯、阿联酋、南非、中东和非洲其他地区）中东和非洲（沙特阿拉伯、阿联酋、南非、中东和非洲其他地区）
Market leaders and key company profiles	Phibro Animal Health Corp Zoetis Inc Kemin Industries Inc Elanco Animal Health Inc Huvepharma EOOD Impextraco NV Virbac SA.

Get more information on this report

Middle East & Africa Feed Anticoccidials Regional Insights

The regional scope of Middle East & Africa Feed Anticoccidials refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.